Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...
A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a ...
According to a meta-analysis of randomized clinical trials (RCTs), pathologic complete response (pCR) was not associated with overall or disease-free survival in patients with rectal cancer, ...
Oncoguard® Liver blood test delivers six times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care. These findings will be presented as late-breaking data ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...
A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...
The Michigan startup uses a proprietary approach called processor-mediated PCR to enable high-plex, low-cost testing in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results